RCC, RENAL CELL CANCER
Clinical trials for RCC, RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new RCC, RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for RCC, RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Matched conditions: RCC, RENAL CELL CANCER
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug cocktail aims to shrink kidney tumors after first treatment fails
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus a targeted therapy (lenvatinib or axitinib) in 36 adults with advanced clear cell kidney cancer that has worsened after initial treatment. The main goal is to see if the combination can …
Matched conditions: RCC, RENAL CELL CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New blood test aims to predict which cancer patients will benefit from immunotherapy
Diagnosis Not yet recruitingThis study is developing a blood test called NeutroFlow that measures specific immune cells (neutrophils) to predict whether cancer patients will benefit from immunotherapy. Researchers will collect blood samples from 600 patients with several types of cancer before they start tr…
Matched conditions: RCC, RENAL CELL CANCER
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC